1-10 of 10
Bernd Dörken, MD, PhD
Close
Sort by
Journal Articles

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Mareike Frick, MD, Christopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, Willy Chan, Marten Jäger, Kenichi Yoshida, MD PhD, Ricarda Seemann, Daniel Nörenberg, MD, Nils Waldhüter, MD, Helga Fleischer-Notter, Friederike Christen, Clemens A. Schmitt, Bernd Dorken, MD PhD, Uwe Pelzer, Marianne Sinn, Tomasz Zemojtel, Seishi Ogawa, MD PhD, Sven Märdian, Adrian Schreiber, MD, Annegret Kunitz, Ulrike Krüger, Elena Mylona, Frederik Damm, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 632.
https://doi.org/10.1182/blood.V130.Suppl_1.632.632
Published: 2017
Journal Articles

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

Olga Blau, MD PhD, Irina Martynkevich, MD PhD, Franziska Behrenbeck, Claudia D. Baldus, MD, Ekaterina Motiko, Sergei Voloshin, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dorken, MD PhD, Igor Wolfgang Blau, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5111.
https://doi.org/10.1182/blood.V130.Suppl_1.5111.5111
Published: 2017
Journal Articles

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

Martin Szyska, PhD, Stefanie Herda, PhD, Stefanie Althoff, Andreas Heimann, Tra My Dang, Bernd Dörken, MD PhD, Thomas Blankenstein, Il-Kang Na, MD
Journal: Blood
Blood (2016) 128 (22): 2162.
https://doi.org/10.1182/blood.V128.22.2162.2162
Published: 2016
Journal Articles

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Olga Blau, MD PhD, Franziska Behrenbeck, Nikola Suckert, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Renate Arnold, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2891.
https://doi.org/10.1182/blood.V128.22.2891.2891
Published: 2016
Journal Articles

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

J. Henry M. Däbritz, MD, Yong Yu, Maja Milanovic, PhD, Jan R. Dörr, Andreas M. Kaufmann, MD, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD PhD, Clemens A. Schmitt, MD
Journal: Blood
Blood (2014) 124 (21): 2240.
https://doi.org/10.1182/blood.V124.21.2240.2240
Published: 2014
Journal Articles

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Rimma Berenstein, Olga Blau, MD PhD, Axel Nogai, MD, Marlies Wächter, Martin Schmidt-Hieber, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3357.
https://doi.org/10.1182/blood.V124.21.3357.3357
Published: 2014
Journal Articles

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Olga Blau, MD PhD, Ekaterina Slonova, Rimma Berenstein, Axel Nogai, MD, Kathrin Rieger, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2576.
https://doi.org/10.1182/blood.V124.21.2576.2576
Published: 2014
Journal Articles

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Anne Flörcken, MD, Schneider Tanja, MD, Anju Singh, MD, Seval Türkmen, MD, Burmeister Thomas, MD PhD, Joannis Anagnostopoulos, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Jörg Westermann, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1006.
https://doi.org/10.1182/blood.V124.21.1006.1006
Published: 2014
Journal Articles

Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma

Rimma Berenstein, Blau Igor Wolfgang, MD, PhD, Axel Nogai, MD, Marlies Wächter, Antonio Pezzutto, MD, PhD, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3149.
https://doi.org/10.1182/blood.V122.21.3149.3149
Published: 2013
Journal Articles

DNMT3A Mutations In AML: Incidence, Prognostic Influence and Association With Other Molecular Markers

Igor Wolfgang Blau, MD, PhD, Rimma Berenstein, Claudia D. Baldus, MD, PhD, Sophie Schlabitz, Asiye Kar, Ruhiye Cay, Annette Sindram, Claudia Seide, Antonio Pezzutto, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2627.
https://doi.org/10.1182/blood.V122.21.2627.2627
Published: 2013